Director, Search & Evaluation Early TA Lead (Haem)

BioSpace

Waltham (MA)

Hybrid

USD 240,000 - 320,000

Full time

7 days ago
Be an early applicant

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

CSL Behring is expanding its external innovation capability and seeking a Director of Search & Evaluation to lead strategic sourcing and evaluation in Haematology. The role anchors within the Therapeutic Area Leadership Team and drives early partnerships, due diligence, and high-potential assets from preclinical to Phase 1.

The hybrid role requires a PhD/MD or equivalent and deep scientific Haematology expertise, with a proven track record in deal execution and cross-functional collaboration

Qualifications

  • Significant tenure in biopharma with significant experience in external innovation, search & evaluation, or business development.
  • Advanced degree required (PhD, MD, or equivalent).
  • Must have deep scientific expertise in Haematology.
  • Proven track record of leading due diligence and closing early-stage deals.
  • Strong network within biotech, academia, and pharma BD organizations.

Responsibilities

  • Lead external sourcing and scouting efforts for preclinical and Phase 1 assets.
  • Co-lead internal reviews of New Product Opportunities within Haematology.
  • Develop and execute early partnering strategies, onboarding approaches and competitive positioning.
  • Drive cross-functional due diligence for each opportunity (scientific, clinical, regulatory, commercial).
  • Partner with BD and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close.

Skills

External innovation
S&E leadership
Business development
Haematology expertise
Due diligence

Education

PhD or MD or equivalent

Job description

CSL is expanding its external innovation capability, and we're looking for a Director of Search & Evaluation to help shape the future of our Haematology portfolio.

We are seeking a Director of Search & Evaluation to lead strategic sourcing and evaluation of external innovation opportunities in the Haematology therapeutic area. Embedded within the Therapeutic Area Leadership Team (TALT), this position will identify and advance high-potential assets from preclinical through Phase 1 clinical stages, shape early partnering strategies, and drive transactions in collaboration with Business Development.

To be hybrid-based onsite (3 days a week) at one of our R&D hub sites: Zurich (CH), Maidenhead (UK), Waltham (US), King of Prussia (US). This position cannot be held remotely.

Main Responsibilities & Accountabilities

Serve as the senior Early S&E leader within the TALT, influencing therapeutic strategy and ensuring external innovation priorities are integrated into portfolio planning.

Lead proactive sourcing and scouting efforts for preclinical and Phase 1 assets, building a robust pipeline of opportunities aligned with TA strategy.

Co-lead internal meetings (with Late Search Lead) focused on evaluating and prioritizing New Product Opportunities (NPOs) within Haematology. NPO meetings are strategic checkpoints where cross-functional teams review potential assets identified by Search and decide whether to advance them for further due diligence and deal negotiations.

Develop and execute early partnering strategies, including onboarding approaches and competitive positioning for priority assets.

Drive cross-functional due diligence for each opportunity, coordinating scientific, clinical, regulatory, and commercial assessments to inform governance decisions.

Transaction Execution: Partner closely with BD and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close, ensuring seamless handoff and execution.

Represent the TA externally, leading sourcing activities at specialized conferences and cultivating relationships with biotech, academia, and investment communities.

Qualifications & Experience Requirements

Significant tenure in biopharma with significant experience in external innovation, search & evaluation, or business development.

Advanced degree required (PhD, MD, or equivalent).

Must have deep scientific expertise in Haematology.

Proven track record of leading due diligence and closing early-stage deals.

Strong network within biotech, academia, and pharma BD organizations.

About CSL Behring

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.

CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.

To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.

Our Benefits

For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.

You Belong at CSL

At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.

To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging

Equal Opportunity Employer

CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Director, Search & Evaluation Early TA Lead (Haem)
Director, Search & Evaluation Early TA Lead (Haem)

CSL • Waltham (MA)

Hybrid
USD 180,000 - 280,000
Director, Search & Evaluation Early TA Lead (Haem)
Director, Search & Evaluation Early TA Lead (Haem)

CSL • Waltham (MA)

Hybrid
USD 210,000 - 300,000
Director, Search & Evaluation Early TA Lead (Haem)
Director, Search & Evaluation Early TA Lead (Haem)

CSL • Massachusetts

Hybrid
USD 150,000 - 190,000
Senior Director, Search & Evaluation Late TA Lead, Immunology
Senior Director, Search & Evaluation Late TA Lead, Immunology

CSL • Waltham (MA)

Hybrid
USD 250,000 - 350,000
Senior Director TA Portfolio Delivery Lead
Senior Director TA Portfolio Delivery Lead

CSL Ltd. ADR • King of Prussia (PA)

Hybrid
USD 180,000 - 240,000
Associate Director, Global Clinical Scientist
Associate Director, Global Clinical Scientist

CSL Ltd. ADR • King of Prussia (PA)

Hybrid
USD 188,000 - 222,000
Associate Director, Strategic Forecasting and Portfolio Analytics
Associate Director, Strategic Forecasting and Portfolio Analytics

BioSpace • King of Prussia (PA)

On-site
USD 150,000 - 190,000
Associate Director, Global Clinical Scientist
Associate Director, Global Clinical Scientist

BioSpace • King of Prussia (PA)

Hybrid
USD 188,000 - 222,000
Principal Clinical Scientist, Clinical Development - Hematology
Principal Clinical Scientist, Clinical Development - Hematology

CSL Ltd. ADR • King of Prussia (PA)

Hybrid
USD 168,000 - 199,000
Associate Director, Analytical Strategy
Associate Director, Analytical Strategy

BioSpace • Waltham (MA)

On-site
USD 180,000 - 240,000